Your Health, We Care
brigatinib is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.
from FDA，2022.02
Indications and Mechanism of Action of BrigatinibBrigatinib is used to treat adu···【more】
Release date：2026-05-22Recommended：74
Mechanism of Action of Brigatinib (Alunbrig)Brigatinib (Alunbrig) is an oral pre···【more】
Release date：2026-05-21Recommended：59
The treatment of locally advanced or metastatic non-small cell lung cancer (NSCL···【more】
Release date：2026-01-05Recommended：42
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
